Dr. Mauro Antonio Dispagna, MD
- Part D claims, 2024
- 326
- Publications
- 5
- Hospital affiliations
- 1
- Industry payments
- $6,046
- Medical group
- 1
- Practice address
- 111 South 11th Street, Philadelphia, PA 19107
- Practice phone
- Call (215) 955-6000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Dispagna's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mauro Antonio Dispagna is a urologist in Philadelphia, Pennsylvania
Dr. Dispagna practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.
Dr. Dispagna's NPI, 1528642626, was assigned on May 6, 2021. Dr. Dispagna holds Pennsylvania license MT222952.
- NPI
- 1528642626NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8325447501
- NPI enumeration date
- May 6, 2021
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (215) 955-6000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mauro Antonio Dispagna practices at 2 locations in Philadelphia, Pennsylvania
Dr. Dispagna's primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000. The NPI Registry lists Dr. Dispagna's practice address as 3400 Spruce St, Philadelphia, PA 19104.
- Thomas Jefferson University HospitalPrimary111 South 11th Street, Philadelphia, PA 19107 · Philadelphia CountyPhone(215) 955-6000
- NPI Registry address3400 Spruce St, Philadelphia, PA 19104 · Philadelphia CountyPhone(215) 955-1000
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data
Dr. Mauro Antonio Dispagna is affiliated with 1 site of care and 1 medical group
Dr. Dispagna's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. The medical group on file is Orlando Health Medical Group.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mauro Antonio Dispagna's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dispagna practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Thomas Jefferson University Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Thomas Jefferson University and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mauro Antonio Dispagna is one of 562 urologists in Pennsylvania
Urology is Dr. Dispagna's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Dispagna is licensed in Pennsylvania.
Specialties and state licenses
- Urology, PennsylvaniaPrimary
Urologists near Dr. Dispagna
Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mauro Antonio Dispagna's patients have a median age of 87
Across all payers, Dmand AI patient panel data puts Dr. Dispagna's median patient age at 87, with 0% women.
Dr. Dispagna's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 87
Patient panel by sex, all payers
- Women0%
- Men100%
Source: Dmand AI Patient Panel Data
Dr. Mauro Antonio Dispagna wrote 326 Medicare Part D claims in 2024
In 2024, Dr. Dispagna wrote 326 Medicare Part D claims for 150 patients. 82% of them were for generic drugs. CMS names the drug for 252 of them, across 13 drugs with 11 or more claims each, at $35,961 in total drug cost. In 2023, CMS named 150 claims across 7 drugs.
Dr. Dispagna's Part D claims by kind of drug, 2024
- Generic267 claims82%
- Brand-name and other59 claims18%
Dr. Dispagna's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Dispagna's Part D claims, 2024
- Antibiotics33%106 of 326 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1502024: 25268%
Drugs named by CMS: 13 in 2024, 7 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Mauro Antonio Dispagna takes part in Medicare
Dr. Dispagna accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mauro Antonio Dispagna has 5 publications on record
Dmand AI links 5 papers to Dr. Dispagna, published from 2017 to 2024. 2024 was the busiest year, with 2. Dr. Dispagna's most frequent co-authors are Steven Richard Smith, MD, Gennady Bratslavsky, MD and Timothy Karl Byler, MD.
Dr. Dispagna's papers by year, 2017 to 2024
Dr. Dispagna's most frequent co-authors
- Steven Richard Smith, MD2 shared papers
- Gennady Bratslavsky, MD1 shared paper
- Timothy Karl Byler, MD1 shared paper
Recent publications by Dr. Dispagna
Int Braz J Urol
See who Dr. Dispagna researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Dispagna works with, so you can find a warm path to the right urologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mauro Antonio Dispagna received $6,046 in industry payments from 2021 to 2025
CMS Open Payments shows 86 general payments to Dr. Dispagna from 18 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 85% of the total. Medtronic, Inc. paid the most, $1,682.
General payments to Dr. Dispagna by program year, 2021 to 2025
General payments to Dr. Dispagna by kind, 2021 to 2025
- Food and beverage$5,14785%
- Travel and lodging$60510%
- Education$2945%
Companies that paid Dr. Dispagna the most, 2021 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Mauro Antonio Dispagna's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mauro Antonio Dispagna
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mauro Antonio Dispagna's NPI number?
Dr. Mauro Antonio Dispagna's NPI number is 1528642626. It was assigned on May 6, 2021, and it is active in the NPI Registry.
What kind of doctor is Dr. Mauro Antonio Dispagna?
Dr. Mauro Antonio Dispagna is a urologist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).
Where does Dr. Mauro Antonio Dispagna practice?
Dr. Dispagna practices at 111 South 11th Street, Philadelphia, PA 19107. Dr. Dispagna also practices at 3400 Spruce St, Philadelphia, PA 19104. Dr. Dispagna's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.
What is Dr. Mauro Antonio Dispagna's office phone number?
The practice phone on file for Dr. Dispagna is (215) 955-6000.
What is Dr. Mauro Antonio Dispagna's medical license number?
Dr. Dispagna holds Pennsylvania license MT222952.
Which hospitals is Dr. Mauro Antonio Dispagna affiliated with?
Dr. Dispagna practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.
What medical group is Dr. Mauro Antonio Dispagna part of?
Dr. Dispagna is linked to Orlando Health Medical Group.
Does Dr. Mauro Antonio Dispagna accept Medicare?
Yes. CMS lists Dr. Dispagna as accepting Medicare assignment.
What drugs does Dr. Mauro Antonio Dispagna prescribe most?
In 2024 Medicare Part D data, Dr. Dispagna's most prescribed drugs by claims were Tamsulosin HCl, Amoxicillin-Clavulanate Potass and Gemtesa.
Has Dr. Mauro Antonio Dispagna received payments from drug or device companies?
CMS Open Payments shows $6,046 in general payments to Dr. Dispagna from 18 companies from 2021 to 2025. The largest total came from Medtronic, Inc.
Show 3 more questionsShow fewer questions
How long has Dr. Mauro Antonio Dispagna been practicing?
Dr. Dispagna's NPI was assigned in 2021.
Does Dr. Mauro Antonio Dispagna do research?
Dmand AI links 5 publications to Dr. Dispagna, published from 2017 to 2024.
Who does Dr. Mauro Antonio Dispagna publish with?
Dr. Dispagna's most frequent co-authors are Steven Richard Smith, MD (2 shared papers), Gennady Bratslavsky, MD (1 shared paper) and Timothy Karl Byler, MD (1 shared paper).
Selling to urology practices?
See urologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card